We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Naturopathic Compound Suppresses Growth of Prostate Cancer Cell Cultures

By LabMedica International staff writers
Posted on 19 Apr 2011
A recent paper by cancer researchers working with prostate cancer cell cultures supports claims of the efficacy of a naturopathic formulation as an anticancer treatment.

Investigators at Indiana University (Indianapolis, USA) evaluated the effects of the dietary supplement ProstaCaid (PC), which contains mycelium from medicinal mushrooms (Ganoderma lucidum, Coriolus versicolor, Phellinus linteus), saw palmetto berry, pomegranate, pumpkin seed, green tea [40% epigallocatechin-3-gallate (EGCG)], Japanese knotweed (50% resveratrol), extracts of turmeric root (BCM-95), grape skin, pygeum bark, sarsaparilla root, Scutellaria barbata, eleuthero root, Job's tears, astragalus root, skullcap, dandelion, coptis root, broccoli, and stinging nettle, with purified vitamin C, vitamin D3, selenium, quercetin, citrus bioflavonoid complex, beta-sitosterolzinc, lycopene, alpha lipoic acid, boron, berberine and 3.3'-diinodolymethane (DIM). More...
The ingredients form a collection of the natural products best known to be rich in anti-inflammatory and antioxidant activities.

In the current study, which was published in the April 4, 2011, online edition of the International Journal of Oncology, the investigators exposed cultures of prostate cancer cells to PC and then evaluated its effects on gene expression, tumor growth, and tumor invasiveness.

They reported that PC treatment inhibited cell proliferation in the population of highly invasive human hormone independent PC-3 prostate cancer cells in a dose- and time-dependent manner. PC suppressed the metastatic behavior of PC-3 cells by the inhibition of cell adhesion, cell migration, and cell invasion. DNA-microarray analysis demonstrated that PC inhibited proliferation through the modulation of expression of CCND1, CDK4, CDKN1A, E2F1, MAPK6, and PCNA genes.

Senior author Dr. Daniel Silva, associate professor of medicine at Indiana University, said, "The formula we studied has been shown to inhibit growth of human androgen dependent as well as independent prostate cancer cells, and suppresses the metastatic potential of these cells. We were able to identify specific genes, which are responsible for growth of human prostate cancer cells and show, on the molecular level, how it affects the cancer cells. Natural compounds in this formula are known to be without the side effects associated with traditional cancer chemotherapy drugs.”

Related Links:
Indiana University



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
PSA Assay
CanAg PSA EIA
New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The new RABTA sets a high standard in laboratory diagnostics (Photo courtesy of Randox)

Pioneering Analyzer with Advanced Biochip Technology Sets New Standard in Lab Diagnostics

A state-of-the-art analyzer combines advanced technology with exceptional efficiency to meet the demanding needs of modern laboratories. Randox Toxicology (Antrim, Ireland) has launched its pioneering... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: How the predictive test works (Photo courtesy of QMUL)

World’s First Clinical Test Predicts Best Rheumatoid Arthritis Treatment

Rheumatoid arthritis (RA) is a chronic condition affecting 1 in 100 people in the UK today, causing the immune system to attack its joints. Unlike osteoarthritis, which is caused by wear and tear, RA can... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.